CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 8-K/A Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Code of ethics change
- 8-K Event Delisting notice
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 8-K Event Other events
Page 3 of 12 · 221 filings